Cargando…

Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage

BACKGROUND: The peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition. METHODS: 145 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Audrey, Mak, Elijah, Stefaniak, James D., Malpetti, Maura, Nicastro, Nicolas, Savulich, George, Chouliaras, Leonidas, Markus, Hugh S., Rowe, James B., O’Brien, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096698/
https://www.ncbi.nlm.nih.gov/pubmed/32265640
http://dx.doi.org/10.3389/fnins.2020.00238
_version_ 1783510892638371840
author Low, Audrey
Mak, Elijah
Stefaniak, James D.
Malpetti, Maura
Nicastro, Nicolas
Savulich, George
Chouliaras, Leonidas
Markus, Hugh S.
Rowe, James B.
O’Brien, John T.
author_facet Low, Audrey
Mak, Elijah
Stefaniak, James D.
Malpetti, Maura
Nicastro, Nicolas
Savulich, George
Chouliaras, Leonidas
Markus, Hugh S.
Rowe, James B.
O’Brien, John T.
author_sort Low, Audrey
collection PubMed
description BACKGROUND: The peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition. METHODS: 145 participants underwent 3T brain MRI and cognitive assessment. 112 were patients with mild cognitive impairment, Alzheimer’s disease, progressive supranuclear palsy, dementia with Lewy bodies, or frontotemporal dementia. PSMD, SVD burden [white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), microbleeds, lacunes], average mean diffusivity (MD), gray matter (GM), white matter (WM), and total intracranial volume were quantified. Robust linear regression was conducted to examine associations between variables. Dominance analysis assessed the relative importance of markers in predicting various outcomes. Regional analyses examined spatial overlap between PSMD and WMH. RESULTS: PSMD was associated with global and regional SVD measures, especially WMH and microbleeds. Dominance analysis demonstrated that among SVD markers, WMH was the strongest predictor of PSMD. Furthermore, PSMD was more closely associated to WMH than with GM and WM volumes. PSMD was associated with WMH across all regions, and correlations were not significantly stronger in corresponding regions (e.g., frontal PSMD and frontal WMH) compared to non-corresponding regions. PSMD outperformed all four conventional SVD markers and MD in predicting cognition, but was comparable to GM and WM volumes. DISCUSSION: PSMD was robustly associated with established SVD markers. This new measure appears to be a marker of diffuse brain injury, largely due to vascular pathology, and may be a useful and convenient metric of overall cerebrovascular burden.
format Online
Article
Text
id pubmed-7096698
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70966982020-04-07 Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage Low, Audrey Mak, Elijah Stefaniak, James D. Malpetti, Maura Nicastro, Nicolas Savulich, George Chouliaras, Leonidas Markus, Hugh S. Rowe, James B. O’Brien, John T. Front Neurosci Neuroscience BACKGROUND: The peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition. METHODS: 145 participants underwent 3T brain MRI and cognitive assessment. 112 were patients with mild cognitive impairment, Alzheimer’s disease, progressive supranuclear palsy, dementia with Lewy bodies, or frontotemporal dementia. PSMD, SVD burden [white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), microbleeds, lacunes], average mean diffusivity (MD), gray matter (GM), white matter (WM), and total intracranial volume were quantified. Robust linear regression was conducted to examine associations between variables. Dominance analysis assessed the relative importance of markers in predicting various outcomes. Regional analyses examined spatial overlap between PSMD and WMH. RESULTS: PSMD was associated with global and regional SVD measures, especially WMH and microbleeds. Dominance analysis demonstrated that among SVD markers, WMH was the strongest predictor of PSMD. Furthermore, PSMD was more closely associated to WMH than with GM and WM volumes. PSMD was associated with WMH across all regions, and correlations were not significantly stronger in corresponding regions (e.g., frontal PSMD and frontal WMH) compared to non-corresponding regions. PSMD outperformed all four conventional SVD markers and MD in predicting cognition, but was comparable to GM and WM volumes. DISCUSSION: PSMD was robustly associated with established SVD markers. This new measure appears to be a marker of diffuse brain injury, largely due to vascular pathology, and may be a useful and convenient metric of overall cerebrovascular burden. Frontiers Media S.A. 2020-03-19 /pmc/articles/PMC7096698/ /pubmed/32265640 http://dx.doi.org/10.3389/fnins.2020.00238 Text en Copyright © 2020 Low, Mak, Stefaniak, Malpetti, Nicastro, Savulich, Chouliaras, Markus, Rowe and O’Brien. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Low, Audrey
Mak, Elijah
Stefaniak, James D.
Malpetti, Maura
Nicastro, Nicolas
Savulich, George
Chouliaras, Leonidas
Markus, Hugh S.
Rowe, James B.
O’Brien, John T.
Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_full Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_fullStr Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_full_unstemmed Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_short Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_sort peak width of skeletonized mean diffusivity as a marker of diffuse cerebrovascular damage
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096698/
https://www.ncbi.nlm.nih.gov/pubmed/32265640
http://dx.doi.org/10.3389/fnins.2020.00238
work_keys_str_mv AT lowaudrey peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT makelijah peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT stefaniakjamesd peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT malpettimaura peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT nicastronicolas peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT savulichgeorge peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT chouliarasleonidas peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT markushughs peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT rowejamesb peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT obrienjohnt peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage